Compare that to typical discontinuation rates of 5% to 10% with GLP-1 receptor agonists
It must not be administered, consumed, compounded for administration, used for self-experimentation, or represented as suitable for the diagnosis, treatment, mitigation, cure, or prevention of any condition
While causation cant be confirmed, the review found enough evidence to recommend caution: lowest dose, shortest duration, and only under medical guidance
Yun Weisholtz is a physician-scientist and advisor with a deep commitment to mentorship and advancing equity in medicine
The first is the science of transdermal delivery, which we'll come to in a moment
J Endocrinol (2015) 226:T85T100